With the former Novartis flu vaccine unit in hand, CSL has big plans for its newly formed flu vaccines unit Seqirus. But it’ll be a bumpy path toward reaching…

Following the June decision by a CDC committee to recommend against any use of AstraZeneca’s FluMist Quadrivalent for the upcoming flu season, a Canadian study…

As the Zika epidemic rages on, scientists are racing to develop vaccines that could quell outbreaks and prevent infections in humans. Now, a group of…

Scientists have been developing vaccines that could stop disease outbreaks more quickly. Now, researchers at the Massachusetts Institute of Technology are…

As the number of Zika cases continues to rise in the U.S., researchers at the National Institutes of Health are launching a clinical trial of a vaccine meant…

Pfizer’s Prevnar 13 sales were down in Q2 after management laid out low projections for the vaccine in 2016. But things could pick up again for Prevnar thanks…

Nearly a year after raising $12 million to advance its universal flu vaccine candidate into human trials, Madison, WI’s FluGen is heading to the clinic. The…

Gaithersburg, MD’s Altimmune has secured a sizable government contract to further develop its nasal spray anthrax vaccine candidate, building on an existing…